Volume 15, Issue 4

Neurotherapeutics is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all Neurotherapeutics articles

October 2018

Myopathy: Recent Progress, Current Therapies, and Future Directions

27 articles in this issue

Myopathy: Recent Progress, Current Therapies, and Future Directions
Andrew L. Mammen
Ricardo H. Roda
Doris G. Leung
Editorial 15 November 2018 Pages: 837 - 839
Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
Perry B. Shieh
Review 09 November 2018 Pages: 840 - 848
The Limb–Girdle Muscular Dystrophies: Is Treatment on the Horizon?
Mary Lynn Chu
Ellen Moran
Review 17 July 2018 Pages: 849 - 862
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments
Johanna Hamel
Rabi Tawil
Review 25 October 2018 Pages: 863 - 871
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease
Samantha LoRusso
Benjamin Weiner
W. David Arnold
Review 18 October 2018 Pages: 872 - 884
Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches
Tokunbor A. Lawal
Joshua J. Todd
Katherine G. Meilleur
Review Open access 07 November 2018 Pages: 885 - 899
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges
Nuria Carrillo
May C. Malicdan
Marjan Huizing
Review 18 October 2018 Pages: 900 - 914
Myopathies Related to Glycogen Metabolism Disorders
Mark A. Tarnopolsky
Review 05 November 2018 Pages: 915 - 927
Pompe Disease: From Basic Science to Therapy
Lara Kohler
Rosa Puertollano
Nina Raben
Review 16 August 2018 Pages: 928 - 942
Diagnosis and Treatment of Mitochondrial Myopathies
Syeda T. Ahmed
Lyndsey Craven
Amy E. Vincent
Review Open access 07 November 2018 Pages: 943 - 953
Skeletal Muscle Channelopathies
Lauren Phillips
Jaya R. Trivedi
Review 19 October 2018 Pages: 954 - 965
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
Mo Zhao
Nika Maani
James J. Dowling
Review Open access 13 November 2018 Pages: 966 - 975
Autoimmune Myopathies: Updates on Evaluation and Treatment
Emer R. McGrath
Christopher T. Doughty
Anthony A. Amato
Review 16 October 2018 Pages: 976 - 994
Inclusion Body Myositis: Update on Pathogenesis and Treatment
Elie Naddaf
Richard J. Barohn
Mazen M. Dimachkie
Review 22 August 2018 Pages: 995 - 1005
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Beth A. Taylor
Paul D. Thompson
Review 24 September 2018 Pages: 1006 - 1017
Ketogenic Diets for Adult Neurological Disorders
Tanya J. W. McDonald
Mackenzie C. Cervenka
Current Perspectives 17 September 2018 Pages: 1018 - 1031
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
Saak Victor Ovsepian
Valerie Bríd O’Leary
Commentary 21 September 2018 Pages: 1032 - 1035
L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease
Baruh Polis
Kolluru D. Srikanth
Abraham O. Samson
Original Article Open access 04 October 2018 Pages: 1036 - 1054
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice
Abdel A. Belaidi
Adam P. Gunn
Ashley I. Bush
Original Article 15 August 2018 Pages: 1055 - 1062
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Ana I. Rodriguez-Perez
Diego Sucunza
Jose L. Labandeira-Garcia
Original Article Open access 09 July 2018 Pages: 1063 - 1081
Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery
Sònia Ramos-Perdigués
Eva Baillés
Luís Pintor
Original Article 31 July 2018 Pages: 1082 - 1092
Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice
Jin-Tao Liu
Sheng-Xi Wu
Fang Kuang
Original Article Open access 15 August 2018 Pages: 1093 - 1111
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy
Robertino Dilena
Jacopo C. DiFrancesco
Maurizio Taglialatela
Original Article 15 August 2018 Pages: 1112 - 1126
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model
Julius W. Kim
J. Robert Kane
Maciej S. Lesniak
Original Article 19 July 2018 Pages: 1127 - 1138
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
Chao Fu
Dongyuan Li
Xingyi Jin
Original Article 17 August 2018 Pages: 1139 - 1157
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
Wen-Jun Tu
Han-Cheng Qiu
Ji-Zong Zhao
Original Article 20 July 2018 Pages: 1158 - 1167
Abstracts from HSG 2018

News 12 October 2018 Pages: 1168 - 1214

Volume 15, Issue 4

Myopathy: Recent Progress, Current Therapies, and Future Directions

Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy

The Limb–Girdle Muscular Dystrophies: Is Treatment on the Horizon?

Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments

Myotonic Dystrophies: Targeting Therapies for Multisystem Disease

Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches

GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges

Myopathies Related to Glycogen Metabolism Disorders

Pompe Disease: From Basic Science to Therapy

Diagnosis and Treatment of Mitochondrial Myopathies

Skeletal Muscle Channelopathies

Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease

Autoimmune Myopathies: Updates on Evaluation and Treatment

Inclusion Body Myositis: Update on Pathogenesis and Treatment

Statin-Associated Muscle Disease: Advances in Diagnosis and Management

Ketogenic Diets for Adult Neurological Disorders

Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?

L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease

Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery

Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice

Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy

A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model

LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway

Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke

Abstracts from HSG 2018

Navigation